Tracker › Companies › NextCure, Inc.
2 No sign of it. We found no public evidence tying NextCure, Inc.'s cuts to AI.
Every tracked 2026 layoff at NextCure, Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 2/100 (Minimal) · 80% interval 2–3 · evidence grade D · US · Pharma / Chemicals
Stated reason: The Board of Directors of NextCure approved a restructuring and workforce reduction plan (the “ Plan ”) intended to better align NextCure’s workforce and operations with the anticipated needs of its business pending the closing of the Merger. The Plan is expected to begin in July 2026 and result in a reduction in force affecting a substantial majority of NextCure’s workforce during the quarter ending September 30, 20…
Why 2: Plant, store or site closure · Drivers: contrary evidence −0.9, industry AI exposure +0.5
Evidence: SEC filing. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.761, industry exposure 0.712, AI investment 0.0, contrary evidence 0.55 · named roles: Computer and Information Systems Managers, General and Operations Managers
Headcount basis: not disclosed
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 1,864 workers
Health Care & Pharma · 589 workers
Health Care & Pharma · 303 workers
Health Care & Pharma · 87 workers
Health Care & Pharma
Health Care & Pharma
